Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

MVM Life Science Partners

Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 61
Average round size
The average size of a deal this fund participated in
Portfolio companies 44
Rounds per year 2.44
Lead investments 21
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 19
Key employees 8
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Medical
  • Health Care
  • Medical Device
  • Pharmaceutical

MVM Life Science Partners is the famous VC, which was founded in 1997. The main department of described VC is located in the London. The fund was located in Europe if to be more exact in United Kingdom.

Besides them, we counted 8 critical employees of this fund in our database.

Considering the real fund results, this VC is 20 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. When the investment is from MVM Life Science Partners the average startup value is 50-100 millions dollars. Comparing to the other companies, this MVM Life Science Partners performs on 3 percentage points more the average number of lead investments. The top amount of exits for fund were in 2015. The fund is constantly included in 2-6 investment rounds annually. The important activity for fund was in 2011.

The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight BioVex, Zipline Medical, Wilson Therapeutics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Pharmaceutical, Health Care.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the MVM Life Science Partners, startups are often financed by XSeed Capital, Stanmore Medical Investments, Scottish Equity Partners. The meaningful sponsors for the fund in investment in the same round are Novo Holdings, Neomed Management, Index Ventures. In the next rounds fund is usually obtained by Index Ventures, HighCape Partners, Novo Holdings.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of MVM Life Science Partners:
Typical Co-investors
MVM Life Science Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after MVM Life Science Partners:

Funds with similar focus

Funds from United Kingdom
Funds with similar focus located in United Kingdom:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AvTech Ventures California, Del Mar, United States
Besterra Japan, Koto
BRC Innovation Boston, Massachusetts, United States
Panoramic Growth Equity England, London, United Kingdom
Rubix Ventures England, London, United Kingdom
Selfco -
SHS Ventures Germany, Saarland, Völklingen
Trilantic Capital Partners New York, New York, United States
Two Small Fish Ventures Canada, Ontario, Toronto

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Health Care
Medical Device
$67M12 Sep 2022 Costa Mesa, California, United States

Nalu Medical

Health Care
Medical Device
$104M17 Feb 2022 Carlsbad, California, United States

Vero Biotech

Health Care
Health Diagnostics
Medical Device
$100M21 Dec 2021 Atlanta, Georgia, United States


Health Care
Medical Device
$102M08 Sep 2021 Irvine, California, United States

eXmoor Pharma

Life Science
$16M11 Mar 2021 Bristol, England, United Kingdom

GT Medical Technologies

Health Care
Medical Device
$16M23 Nov 2020 Tempe, Arizona, United States

Paragon 28

14 Aug 2020 Colorado, United States


Business/Productivity Software
Metal Containers and Packaging
Supply Chain Management
$67M28 Apr 2020 Zurich, Zurich, Switzerland


Health Diagnostics
Medical Device
$14M27 Apr 2020 Irvine, California, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent MVM Life Science Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: